# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001601830-22-000017
Filing Date
2022-04-28
Accepted
2022-04-28 16:01:36
Documents
15
Period of Report
2022-06-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | rxrx_proxystatement2022.htm | DEF 14A | 580801
2 |  | image_0a.jpg | GRAPHIC | 125848
3 |  | image_1a.jpg | GRAPHIC | 98963
4 |  | image_2a.jpg | GRAPHIC | 569821
5 |  | image_3a.jpg | GRAPHIC | 118473
6 |  | img_2022proxystatementa.jpg | GRAPHIC | 1188031
7 |  | img_aboutrecursiona.jpg | GRAPHIC | 1357933
8 |  | img_proposal1a.jpg | GRAPHIC | 2261049
9 |  | proxycard-01a.jpg | GRAPHIC | 875222
10 |  | proxycard-02a.jpg | GRAPHIC | 757075
11 |  | rec_proxydividerxv2a.jpg | GRAPHIC | 624790
12 |  | rec_proxyxfinalxtocx1a.jpg | GRAPHIC | 302277
13 |  | signaturea.jpg | GRAPHIC | 580233
14 |  | vote-01a.jpg | GRAPHIC | 1965451
15 |  | vote-02a.jpg | GRAPHIC | 1007138
| Complete submission text file | 0001601830-22-000017.txt |  | 16216778

Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40323 | Film No.: 22866343
SIC: 2836 Biological Products, (No Diagnostic Substances)